A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
Clinical trial NCT02040779 · COMPLETED
Trial details
- NCT number
- NCT02040779
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-26
- Primary completion
- 2014-12-24
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.